|
Report ID
|
103222 |
|
Drug Identification Number
|
02473968 |
|
Brand name
|
ODAN-SODIUM POLYSTYRENE SULFONATE |
|
Common or Proper name
|
Sodium Polystyrene Sulfonate Oral/Rectal Suspension |
|
Company Name
|
ODAN LABORATORIES LTD |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
SODIUM POLYSTYRENE SULFONATE |
|
Strength(s)
|
250MG |
|
Dosage form(s)
|
SUSPENSION |
|
Route of administration
|
ORAL
RECTAL |
|
Packaging size
|
60 mL |
|
ATC code
|
V03AE |
|
ATC description
|
ALL OTHER THERAPEUTIC PRODUCTS |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
2020-01-13 |
|
Actual start date
|
2020-01-13 |
|
Estimated end date
|
2022-01-30 |
|
Actual end date
|
2022-06-02 |
|
Shortage status
|
Resolved |
|
Updated date
|
2022-06-07 |
|
Company comments
|
Delay in testing of the drug |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
[email protected]
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |
